Former PM Ehud Olmert joins medical cannabis company Univo

Olmert, the company said, will "help promote Univo's business goals both in Israel and globally, and will support the company’s future fundraising efforts."

By
April 5, 2019 05:24
2 minute read.
Former prime minister Ehud Olmert at the 7th Annual JPost Conference in NY

Former prime minister Ehud Olmert at the 7th Annual JPost Conference in NY. (photo credit: MARC ISRAEL SELLEM)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

ormer Israeli Prime Minister Ehud Olmert has joined Ashkelon-based medical cannabis company Univo as an investor and professional adviser, the company announced on Wednesday.
 
Olmert, the company said, will “help promote Univo’s business goals both in Israel and globally, and will support the company’s future fundraising efforts.”
 
Olmert, who served as prime minister from January 2006 to March 2009, is currently the head of Israel’s Public Council for Healthy Lifestyles, and chairs the advisory board of venture capital firm Genesis Angels, which has invested in top medical technology companies in Israel.
 
Founded in 2016, Tel Aviv Stock Exchange-traded Univo possesses licenses for the cultivation, research and development, production, and distribution of its own cannabis product.
 
The company, led by CEO Golan Bitton, is currently developing a new 750 square-meter facility, including an on-site R&D laboratory, to cultivate a wide variety of cannabis strains.
 
“The tech revolution has entered the medical cannabis space and is expediting all R&D, manufacturing and even regulatory procedures, with the goal of relieving pain for patients suffering from a spectrum of diseases,” said Olmert.
 
“Israel is stepping up and joining the world’s most progressive nations in developing a pivotal local industry that has the potential to contribute to global medical cannabis R&D efforts,” he said.
 
“After I examined Israel’s top medical cannabis companies, I chose to contribute my experience and knowledge to Univo, because I believe that Univo has the best chance of becoming an independent entity when it comes to manufacturing and distributing top cannabis-based products. I am thankful for the opportunity to step in and help this company become a global leader.”
 
The global medical cannabis market was valued at $8.3 billion in 2017, and is projected to soar in value to $28b. by 2024, according to a recent report by Energias Market Research. In January, the Israeli government approved exports of domestically-grown medical cannabis to the worldwide legal market.
 
Ido Hagag, a real estate developer and one of Univo’s major investors, said Olmert’s “connections with global markets and his capabilities in the health sector” will enable the company to improve patient care worldwide.
 
“We’re proud to have Mr. Olmert supporting our vision and putting his trust in our manufacturing and supply chain. This is a major milestone for Univo that soon enough will bear fruit,” said Hagag.
 
Olmert is the second former prime minister to enter the medical cannabis industry to date. Since September, Ehud Barak has served as chairman of Canndoc-InterCure, a holding company of Israeli medical cannabis firms.
 
Barak is responsible for the company’s global growth strategy and the development of international business. The company is currently examining going public on the NASDAQ stock market.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

A general view of Tel Aviv's skyline is seen through a hotel window in Tel Aviv, Israel May 15, 2017
April 18, 2019
Hi-tech companies raise $1.55 billion in first quarter of 2019

By EYTAN HALON